ChromaDex to Present at Benzinga’s Global Small Cap Conference on May 13, 2021
May 03 2021 - 6:33AM
Business Wire
ChromaDex Corp. (NASDAQ: CDXC) is scheduled to participate in a
virtual presentation at the Benzinga Small Cap Conference on
Thursday, May 13, 2021 at 11:30am ET (8:30am PT). ChromaDex CEO,
Rob Fried, will also be presenting on a panel in the Transformative
Healthcare track, entitled “Investing in Longevity Science: The New
Drugs & Therapies Designed to Prolong Your Lifespan.” The panel
is scheduled for Thursday, May 13, 2021 at 1:20pm ET.
The Global Small Cap Conference is a day dedicated to bridging
the gap between Small Cap companies, investors and traders. The
event will have multiple days of networking and education in a
virtual setting.
A webcast of the company presentation will be posted under the
investor relations section of ChromaDex’s website at
www.chromadex.com, or can be accessed at
https://investors.chromadex.com/events-and-presentations/default.aspx.
A replay of the presentation will be available following the
event.
To learn more about small-cap innovation and investing at the
Benzinga Global Small Cap Conference, click here.
About ChromaDex:
ChromaDex Corp. is a global bioscience company dedicated to
healthy aging. The ChromaDex team, which includes world-renowned
scientists, is pioneering research on nicotinamide adenine
dinucleotide (NAD+), levels of which decline with age. ChromaDex is
the innovator behind NAD+ precursor nicotinamide riboside (NR),
commercialized as the flagship ingredient Niagen®. Nicotinamide
riboside and other NAD+ precursors are protected by ChromaDex’s
patent portfolio. ChromaDex delivers Niagen® as the sole active
ingredient in its consumer product Tru Niagen® available at
www.truniagen.com and through partnerships with global retailers
and distributors. ChromaDex maintains a website at
www.chromadex.com to which ChromaDex regularly posts copies of its
press releases as well as additional and financial information
about the Company.
About Benzinga:
Benzinga is a leading financial media company dedicated to
making information easier to consume. Benzinga's news desk is
constantly breaking stories and moving billions of dollars of
market capitalization through its real-time news tool, Benzinga
Pro. Benzinga's original content is syndicated to 70 partner
websites including Yahoo! Finance MSN, CNNMoney, Fox Business and
MarketWatch.
Forward-Looking Statements:
This release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities and Exchange Act of 1934, as
amended. Statements that are not a description of historical facts
constitute forward-looking statements and may often, but not
always, be identified by the use of such words as "expects",
"anticipates", "intends", "estimates", "plans", "potential",
"possible", "probable", "believes", "seeks", "may", "will",
"should", "could" or the negative of such terms or other similar
expressions. More detailed information about ChromaDex and the risk
factors that may affect the realization of forward-looking
statements is set forth in ChromaDex's Annual Report on Form 10-K
for the fiscal year ended December 31, 2019, as amended,
ChromaDex's Quarterly Reports on Form 10-Q and other filings
submitted by ChromaDex to the SEC, copies of which may be obtained
from the SEC's website at www.sec.gov. Readers are cautioned not to
place undue reliance on these forward-looking statements, which
speak only as of the date hereof, and actual results may differ
materially from those suggested by these forward-looking
statements. All forward-looking statements are qualified in their
entirety by this cautionary statement and ChromaDex undertakes no
obligation to revise or update this release to reflect events or
circumstances after the date hereof.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210503005181/en/
ChromaDex Investor Relations Contact: Brianna Gerber,
Vice President of FP&A and Investor Relations 949-419-0288 ext.
127 briannag@chromadex.com
ChromaDex Media Contact: Alex Worsham, Vice President of Global
Marketing and Communications 310-388-6706 ext. 689 alexw@chromadex.com
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Aug 2024 to Sep 2024
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Sep 2023 to Sep 2024